Using Immersive Virtual Reality for the Upper Limb Rehabilitation of Post-stroke Subjects

March 17, 2025 updated by: University Hospital of Ferrara

Using Immersive Virtual Reality for the Upper Limb Rehabilitation of Post-stroke Subjects: a Multicenter Randomized Control Trial

Stroke produces brain damages that results in sensory, motor, and cognitive impairments which reduce the patient's quality of life and social participation. Upper limb recovery is a complex process whose goal is to allow the patients to gain, in part or completely, independence in daily living activities, for that it represents one of the most important rehabilitation focus. Virtual reality is a fairly recent approach able to simulate concrete movements and functional tasks in a higher dosage compared to other therapies. It seems that the use of VR could improve limb function, however, the amount of this gain is still unclear because of insufficient evidence. This study aims at quantitatively investigating the effectiveness of an HMD immersive virtual reality system on the upper limb functioning in subacute stroke survivors.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Ferrara, Italy, 44124
        • Recruiting
        • Ferrara University Hospital
        • Principal Investigator:
          • Sofia Straudi, MD, PhD
        • Sub-Investigator:
          • Andrea Baroni, PT, PhD
        • Contact:
        • Sub-Investigator:
          • Antonino Casile, PhD
        • Sub-Investigator:
          • Giulia Fregna, PT, MSc, PhD student

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • diagnosis of first, ischemic or hemorrhagic, stroke verified by brain imaging within 4 week
  • upper limb motor impairment defined by an upper extremity score <55 on the Fugl-Meyer Assessment

Exclusion Criteria:

  • neurological conditions in addition to stroke that may affect motor function
  • other medical conditions likely to interfere with the ability to safely complete the study protocol
  • impaired cognitive functioning that influences the ability to give informed consent
  • severe neuropsychological disorders
  • visual impairment
  • severe upper-limb pain defined as > 7 on the Visual Analogue Scale

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VR group
All participants will receive an hour of VR training 5 times/week for 4 weeks within the daily rehab routine.
Four tasks, uni and bi-manuals, will be proposed for the treatment of the patient's paretic upper limb in virtual-apartment for improving the relevance and the transferability of the movements requested.
Other Names:
  • Head-mounted display
No Intervention: Control group
Participants will receive the usual rehabilitation activities due to their clinical needs (physical therapy, speech therapy, etc) for 5 times/week over 4 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in upper limb impairment
Time Frame: Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
Motor recovery will be assessed through the Fugl Meyer Assessment - Upper Extremity
Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Spasticity
Time Frame: Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
Spasticity grade at the paretic upper limb will be measured with the Ashworth Scale (0-5), in which higher scores are related to more severe muscle hypertonia
Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
Change in Activities of Daily Living
Time Frame: Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
Patient's independence will be quantified with the Barthel Index
Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
Change in perceived quality of life
Time Frame: Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
Stroke Impact Scale 2.0 will be performed for investigating the perceived quality of life, higher scores indicate better quality of life perceived
Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
Kinematic data
Time Frame: Parameters changes (e.g. hand peak velocities) before (T0) and after (T1) the 4 weeks of treatment
Instrumental data of hand movements registered during the sessions (relevant kinematic indexes will be recorded and offline analyzed such as hand trajectories and peak velocity)
Parameters changes (e.g. hand peak velocities) before (T0) and after (T1) the 4 weeks of treatment
Electroencephalogram
Time Frame: Data changes before (T0) and after (T1) the 4 weeks of treatment (4 weeks) and at 6-month follow-up (T2)
The EEG signals will be measured by means of a 32-channel cap, according to the International 10-20 system, recorded and monitored by computerized devices.
Data changes before (T0) and after (T1) the 4 weeks of treatment (4 weeks) and at 6-month follow-up (T2)
Treatment satisfaction
Time Frame: After 4 weeks
The satisfaction related to the virtual training will be investigated through a specific questionnaire
After 4 weeks
Embodiment
Time Frame: After 4 weeks
The embodiment feeling will be analyzed with the Gonzalez-Franco questionnaire
After 4 weeks
Cybersickness
Time Frame: After 4 weeks
For monitoring undesirable events the Simulator Sickness Questionnaire will be used
After 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

January 30, 2023

First Submitted That Met QC Criteria

March 17, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 17, 2025

Last Verified

November 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sub-acute Stroke

Clinical Trials on Virtual Reality

Subscribe